Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sarepta Therapeutics, Inc. - Common Stock
(NQ:
SRPT
)
17.98
+0.25 (+1.41%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sarepta Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
36
37
Next >
This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
↗
November 05, 2025
Via
Benzinga
Sarepta Therapeutics Shares Plummet as Key DMD Treatments Miss Primary Endpoint in Late-Stage Trial
November 04, 2025
Sarepta Therapeutics Inc. (NASDAQ: SRPT) experienced a dramatic downturn in its stock valuation today, November 4, 2025, following the announcement of disappointing results from a pivotal late-stage...
Via
MarketMinute
Topics
Death
Which stocks are experiencing notable movement on Tuesday?
↗
November 04, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Sarepta Therapeutics Stock Crashes After-Hours On DMD Trial Failure, Q3 Print — Retail Still Sees Long-Term Comeback
↗
November 03, 2025
Via
Stocktwits
Earnings Scheduled For November 3, 2025
↗
November 03, 2025
Via
Benzinga
A Peek at Sarepta Therapeutics's Future Earnings
↗
October 31, 2025
Via
Benzinga
Gold Falls Over 1%; Uber Shares Decline After Q3 Results
↗
November 04, 2025
Via
Benzinga
Sarepta Faces Investor Skepticism As Duchenne Data Falls Short Of Statistical Significance
↗
November 04, 2025
Sarepta's Duchenne trial missed its main goal but showed trends favoring treatment; Q3 earnings topped estimates amid Elevidys sales weakness.
Via
Benzinga
Tuesday's session: top gainers and losers
↗
November 04, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It
↗
November 04, 2025
Enough though Sarepta shares are crashing, "Pharma Bro" Martin Shkreli says he still likes the stock.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
November 04, 2025
Via
Benzinga
These stocks are gapping in today's session
↗
November 04, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Insperity Posts Downbeat Q3 Results, Joins IAC, Archer-Daniels-Midland And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
November 04, 2025
Via
Benzinga
Tuesday's pre-market session: top gainers and losers
↗
November 04, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 04, 2025
Via
Benzinga
Dow Futures Edge Lower On Pullback Fears: PLTR, SRPT, TSLA, AMD Among Stocks To Watch
↗
November 04, 2025
While Dow Jones futures were down by 0.72% at the time of writing, the S&P 500 futures fell 1.02%.
Via
Stocktwits
Topics
ETFs
Stocks
Why Upwork Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
↗
November 04, 2025
Via
Benzinga
Sarepta Therapeutics Stock Is Tumbling After The Close: Here's Why
↗
November 03, 2025
Sarepta shares are plunging in extended trading Monday after the company reports third-quarter results and provided an update on its ESSENCE study.
Via
Benzinga
These stocks are moving in today's after hours session
↗
November 03, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
Sarepta Crashes After Two Muscular Dystrophy Drugs Fail Confirmatory Tests
↗
November 03, 2025
Sarepta stock crashed Monday after the biotech company said two of its muscular dystrophy drugs failed confirmatory tests.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 03, 2025
Via
Benzinga
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
November 03, 2025
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
↗
November 03, 2025
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.
Via
Benzinga
Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results
October 27, 2025
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Tradr Unleashes 2X Single-Stock Gold ETFs, Reshaping Short-Term Gold Investment Landscape
October 23, 2025
New York, NY – October 23, 2025 – Tradr, a prominent innovator in the Exchange-Traded Fund (ETF) market, has today significantly expanded its product suite with the launch of nine new single-stock 2X...
Via
MarketMinute
Topics
Artificial Intelligence
Derivatives
ETFs
Tradr Launches 9 Single-Stock 2X ETFs With First-Of-Its-Kind OpenDoor, Gold And AI Exposure
↗
October 23, 2025
The new ETFs include the first-of-their-kind gold and AI plays, giving traders targeted exposure without using margin or complex options.
Via
Benzinga
Topics
Artificial Intelligence
ETFs
Tradr Debuts Leveraged ETFs on BLSH, DASH, FLY, IREN, NEM, OPEN, QS, SRPT & WULF
↗
October 23, 2025
Funds seek to provide 200% long exposure on a variety of industry leaders
Via
Stocktwits
Topics
ETFs
What's Going On Sarepta Stock On Wednesday?
↗
October 08, 2025
Sarepta prepares to present new data on Duchenne and limb-girdle muscular dystrophy gene therapy programs this week.
Via
Benzinga
Why Sarepta Therapeutics Stock Is Rising Nearly 5% Premarket
↗
October 08, 2025
Investors turned upbeat ahead of Sarepta’s data presentations in Vienna, where the company is expected to share new Duchenne muscular dystrophy results and updates from its broader gene therapy...
Via
Stocktwits
Topics
Death
Leap Therapeutics (LPTX) Plummets Over 20% Amidst Profit-Taking and Volatility Ahead of Key Clinical Data
October 03, 2025
Boston, MA – October 3, 2025 – Leap Therapeutics, Inc. (NASDAQ: LPTX) experienced a sharp downturn in its stock performance today, with shares falling by over 20% in intraday trading. This significant...
Via
MarketMinute
< Previous
1
2
3
4
5
6
7
8
9
...
36
37
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
